Indoco’s CRO AnaCipher Wins ANVISA Brazil Approval for Clinical and Bioanalytical Facilities, Opening BA/BE Work for Latin America

Indoco Remedies’ Hyderabad-headquartered contract research arm AnaCipher has secured ANVISA approval for its clinical and bioanalytical facilities after a March–April 2026 inspection, clearing it to run bioavailability and bioequivalence studies for Brazilian regulatory submissions, a gateway to Latin America’s largest pharma market.